Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A couple of major acquisitions helped the healthcare giant boost revenue to an all-time high in the third quarter.
As the new year approaches, though, investors are more focused on the future than the past. Will 2018 be Johnson & Johnson's best year yet? Probably yes. And probably no.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Stock
€145.86
-0.120%
The stock is one of the favorites of our community with 41 Buy predictions and 1 Sell predictions.
With a target price of 192 € there is a positive potential of 31.63% for Johnson & Johnson compared to the current price of 145.86 €.
